BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3816412)

  • 1. Antidepressant-binding sites in brain and platelets.
    Langer SZ; Galzin AM; Lee CR; Schoemaker H
    Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
    Marcusson JO; Ross SB
    Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1.
    Schloss P; Betz H
    Biochemistry; 1995 Oct; 34(39):12590-5. PubMed ID: 7548008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant binding: implications for the mode of action and the biology of depression.
    Hrdina PD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):457-62. PubMed ID: 6320297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant binding to the porcine and human platelet serotonin transporters.
    Humphreys CJ; Levin J; Rudnick G
    Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity binding of 3H-imipramine in brain and platelets: relevance to depression and antidepressant drugs.
    Langer SZ; Sette M; Raisman R; Briley M
    Adv Biochem Psychopharmacol; 1982; 31():171-7. PubMed ID: 7044053
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
    Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
    Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.